{Etokimab: A Deep Analysis into the 2022981-44-6 Antibody Etokimab, designated by the specific identifier 2022981-44-6, represents a novel antibody currently subject to therapeutic evaluation. This biologic agent, https://www.targetmol.com/compound/etokimab